Evidence map›Paper›PMID 22278412›Full record

ArticleGene therapy2012

Reprogramming axonal behavior by axon-specific viral transduction.

B A Walker, U Hengst, H J Kim, N L Jeon, E F Schmidt, N Heintz, T A Milner, S R Jaffrey

Open access · bronzeAbstract read
In one paragraph

Article in Gene therapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Disruption of G3BP1 granules promotes mammalian CNS and PNS axon regeneration.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Local translation in neurons: visualization and function.Nature structural & molecular biology · 2019
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Targeting axonal protein synthesis in neuroregeneration and degeneration.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2015
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Intra-axonal translation of RhoA promotes axon growth inhibition by CSPG.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

B A WalkerDepartment of Pharmacology, Weill Medical College, Cornell University, New York, NY 10065, USA.
U Hengst
H J Kim
N L Jeon
E F Schmidt
N Heintz
T A Milner
S R Jaffrey
Cornell University · USRockefeller University · USSeoul National University · KR

Funding

ULTRASTRUCTURAL INTERACTIONS OF OPIOIDS IN HIPPOCAMPUSR01DA008259 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI MILNER, TERESA A · 1993 to 2019
$6.4M
PHARMACOLOGY AND NEUROSCIENCE OF DRUG ABUSET32DA007274 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI SZETO, HAZEL H · 1991 to 2011
$4.8M
Uncovering polyadenylation pathways in neuronal signalingR01NS056306 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JAFFREY, SAMIE R · 2007 to 2018
$4.2M
Intra-axonal signaling pathways triggered by attractive guidance cues.R01MH096702 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HENGST, ULRICH · 2012 to 2016
$2.1M
MENOPAUSAL CHANGES IN HYPOTHALAMUS AND HYPERTENSION SUSCEPTIBILITYR01HL098351 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MILNER, TERESA A · 2011 to 2014
$1.7M
NHLBI NIH HHS R01 HL098351NIDA NIH HHS DA08259NIDA NIH HHS R01 DA008259NIDA NIH HHS T32 DA007274NIDA NIH HHS T32DA007274NIMH NIH HHS R01 MH096702NINDS NIH HHS NS56306NINDS NIH HHS R01 NS056306PHS HHS ML096571PHS HHS ML098351
6 · The paper itself

Abstract

The treatment of axonal disorders, such as diseases associated with axonal injury and degeneration, is limited by the inability to directly target therapeutic protein expression to injured axons. Current gene therapy approaches rely on infection and transcription of viral genes in the cell body. Here, we describe an approach to target gene expression selectively to axons. Using a genetically engineered mouse containing epitope-labeled ribosomes, we find that neurons in adult animals contain ribosomes in distal axons. To use axonal ribosomes to alter local protein expression, we utilized a Sindbis virus containing an RNA genome that has been modified so that it can be directly used as a template for translation. Selective application of this virus to axons leads to local translation of heterologous proteins. Furthermore, we demonstrate that selective axonal protein expression can be used to modify axonal signaling in cultured neurons, enabling axons to grow over inhibitory substrates typically encountered following axonal injury. We also show that this viral approach also can be used to achieve heterologous expression in axons of living animals, indicating that this approach can be used to alter the axonal proteome in vivo. Together, these data identify a novel strategy to manipulate protein expression in axons, and provides a novel approach for using gene therapies for disorders of axonal function.

Indexed as

Genetic VectorsAdenylyl CyclasesAnimalsAxonsGene TargetingMiceNerve RegenerationRibosomesSindbis VirusSpinal CordAdenylyl Cyclases

Identifiers

PMID22278412
PMCPMC3426632
OpenAlexW2041940244

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.